Your browser is no longer supported. Please, upgrade your browser.
Settings
NXTM Nxstage Medical, Inc. daily Stock Chart
NXTM [NASD]
Nxstage Medical, Inc.
Index- P/E- EPS (ttm)-0.09 Insider Own2.00% Shs Outstand65.32M Perf Week5.81%
Market Cap1.65B Forward P/E816.77 EPS next Y0.03 Insider Trans-4.91% Shs Float63.28M Perf Month2.55%
Income-5.80M PEG- EPS next Q-0.02 Inst Own99.50% Short Float6.09% Perf Quarter9.52%
Sales363.20M P/S4.55 EPS this Y37.60% Inst Trans0.21% Short Ratio9.63 Perf Half Y22.44%
Book/sh3.09 P/B8.19 EPS next Y137.50% ROA-1.90% Target Price27.83 Perf Year31.94%
Cash/sh0.93 P/C27.20 EPS next 5Y20.00% ROE-3.00% 52W Range13.49 - 26.83 Perf YTD15.56%
Dividend- P/FCF612.56 EPS past 5Y11.10% ROI-7.60% 52W High-5.63% Beta0.35
Dividend %- Quick Ratio2.00 Sales past 5Y13.40% Gross Margin41.30% 52W Low87.69% ATR0.99
Employees3600 Current Ratio3.00 Sales Q/Q6.40% Oper. Margin-1.20% RSI (14)53.32 Volatility2.92% 3.56%
OptionableYes Debt/Eq0.07 EPS Q/Q90.30% Profit Margin-1.60% Rel Volume0.76 Prev Close25.54
ShortableYes LT Debt/Eq0.06 EarningsNov 03 BMO Payout- Avg Volume399.77K Price25.32
Recom1.70 SMA20-0.34% SMA503.41% SMA20021.51% Volume305,613 Change-0.86%
Jun-28-16Upgrade Northland Capital Market Perform → Outperform
Mar-31-16Resumed Piper Jaffray Overweight $23 → $18.50
Dec-11-15Initiated Sterne Agee CRT Buy
May-03-13Reiterated Feltl & Co. Hold $11.50 → $12
Mar-01-13Reiterated Feltl & Co. Hold $13 → $11.50
Dec-04-12Downgrade Northland Securities Outperform → Market Perform
Sep-07-12Initiated Northland Securities Outperform $18
Feb-18-11Reiterated Rodman & Renshaw Mkt Underperform $15 → $18
Dec-03-10Initiated Jefferies Buy $27
Oct-14-10Downgrade Rodman & Renshaw Mkt Perform → Mkt Underperform $15
Sep-15-10Initiated Feltl & Co. Buy $19
Jul-26-10Downgrade Rodman & Renshaw Mkt Outperform → Mkt Perform
May-06-10Reiterated Rodman & Renshaw Mkt Outperform $11 → $14
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $11
Jun-05-09Upgrade William Blair Mkt Perform → Outperform
Aug-06-08Reiterated SMH Capital Buy $8 → $7
Aug-06-08Reiterated Canaccord Adams Hold $7 → $4.75
Jul-29-08Initiated SMH Capital Buy $8
May-14-08Reiterated JMP Securities Mkt Outperform $13 → $10
May-13-08Downgrade William Blair Outperform → Mkt Perform
Dec-09-16 09:13AM  Haemonetics Introduces Upgraded NextGen DMS 4 Software
08:44AM  Henry Schein Buys Stake in Marrodent; Spurs Polish Foothold
Dec-08-16 11:59AM  Steris Poor Q2 Disappoints, Synergy Health Raises Hope
09:13AM  Masimo (MASI) Hits 52-Week High on Solid Growth Prospects
09:11AM  Henry Schein's Q3 Results Impress, Pricing Pressure a Drag
Dec-07-16 08:16AM  Genomic Health: Cancer Test Business Strong, Q3 Dismal
08:12AM  Medtronic Endurant II/IIs Stent Graft System Wins CE Mark
07:36AM  GNC Faces Poor Domestic Sales, Margins Still Under Pressure
Dec-06-16 07:58AM  Omnicell Unveils XT Series Automated Dispensing System
Dec-05-16 09:30AM  Zacks Industry Outlook Highlights: Johnson & Johnson, Medtronic, Zimmer Biomet and Nxstage Medical
09:15AM  Bruker Ties Up with IPCN to Boost Preclinical Imaging Suite
09:00AM  Nxstage Medical (NXTM): An Off-the-Radar Potential Winner
08:10AM  Boston Scientific (BSX) Inks $75 Million Deal with Neovasc
03:27AM  Matson, Inc. (MATX): Are Hedge Funds Right About This Stock? at Insider Monkey
Dec-02-16 07:53AM  Medtronic Introduces CoreValve Evolut R System in Japan
07:44AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : December 2, 2016
07:40AM  Omnicell to Buy Ateb, Expand in Adherence Tools Market
07:29AM  Medtronic Stock Falls on Mixed 2Q; Positive on HeartWare Buy
Dec-01-16 08:24AM  Medtronic Partners UH to Launch Integrated Health Solutions
Nov-30-16 07:32PM  Is NxStage Medical, Inc. (NXTM) A Good Stock To Buy Right Now? at Insider Monkey
07:38AM  Medtronic's Less-Invasive HVAD Implant System Gets CE Mark
Nov-29-16 09:14AM  NuVasive: Q3 Results Lack Shine, Spine Market Holds Promise
09:03AM  Edward Lifesciences (EW) to Buy Israel's Valtech Cardio
Nov-28-16 07:58AM  Walgreen Boots: Mixed Q4, Awaits Rite Aid Deal Closure
07:38AM  Haemonetics (HAE) Hits a 52-Week High on Solid Prospects
Nov-25-16 08:40AM  STERIS (STE): Q2 Results Disappoint, Acquisitions Bode Well
08:30AM  Can Nxstage Medical (NXTM) Stock Continue to Grow Earnings?
07:55AM  Zimmer Biomet Chosen as IUIH Preferred Orthopaedic Partner
Nov-23-16 08:11AM  Quest Diagnostics' QuestDirect Now in Colorado & Missouri
05:47AM  IDEXX: Strength in International Business & CAG Continues
Nov-22-16 10:06AM  Medtronic (MDT) Tops Q2 Earnings, Lowers FY17 Guidance -5.19%
08:19AM  Haemonetics: Medical Center of Plano Picks BloodTrack
07:53AM  Quest Diagnostics at 52-Week High on Solid Q3 & Prospects
Nov-21-16 09:09AM  Medtronic's (MDT) Heli-FX EndoAnchor System Data Positive
07:35AM  Bruker Buys OST, To Expand in Superconducting Wires Market
Nov-18-16 10:53AM  Why Nxstage Medical (NXTM) Could Be Positioned for a Surge
06:04AM  CVS Health (CVS): Sluggish Q3, Guidance Cut Pose Concerns
Nov-17-16 08:00AM  VWR Poised on Solid Fundamentals, Margin Pressure Remains
07:22AM  St. Jude Medical's MOMENTUM 3 IDE Study Results Encourage
07:16AM  Boston Scientific (BSX) Reports Positive Data on HeartLogic
07:14AM  Medtronic: FDA Okays Solitaire Device for Expanded Use
06:48AM  BioScrip: Guidance Disappoints, Home Solutions Raises Hope
Nov-16-16 04:45PM  Cardiovascular Systems at 52-Week High on Huge Prospects
09:58AM  AngioDynamics (ANGO) Announces 2.5M Secondary Offering
09:30AM  Zacks.com featured highlights: Cisco Systems, Cardiovascular Systems, Five9, Generac Holdings and Nxstage Medical
09:21AM  Zimmer Biomet (ZBH) Announces Positive Data from IDE Trial
09:15AM  TransEnterix to Present Senhance Robotic System at AAGL
08:00AM  New Data Shows Better Outcomes, Higher Quality of Life, Lower Cost of Care, and Increased Likelihood for Transplant with More Frequent Hemodialysis Using the NxStage System One PR Newswire
Nov-15-16 02:39PM  Top Stocks with Big Potential Catch-Up Moves
11:11AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q3, 2016 By the Numbers : November 15, 2016
09:30AM  Zacks.com featured highlights: Nxstage Medical, Brooks Automation, KVH Industries, Tilly's and EnerSys
07:07AM  Medtronic's (MDT) MRI CRT-D Device Gains FDA Approval
Nov-14-16 08:40AM  5 Liquid Stocks to Put Your Money On
08:02AM  Medtronic Launches Orthopedic Solutions for Joint Surgery
Nov-11-16 01:04PM  NXSTAGE MEDICAL, INC. Financials
Nov-09-16 10:45AM  Tamarack Capital Managements Ariad Pharmaceuticals, Inc. (ARIA) Holding Carries It To Strong Q3 Gains at Insider Monkey
09:30AM  Zacks.com featured highlights: McDermott International, NVIDIA, Nxstage Medical, Melco Crown Entertainment and Anika Therapeutics
09:30AM  Zacks.com featured highlights: Heska, Teradyne, Nxstage Medical, Unifi and Rollins
Nov-08-16 07:26AM  No Clue of Upcoming Trends? Buy These Efficient Stocks
06:24AM  On the Lookout for Earnings Beat? 5 Top Picks
Nov-04-16 08:18AM  NxStage Medical, Inc. breached its 50 day moving average in a Bullish Manner : NXTM-US : November 4, 2016
Nov-03-16 11:18AM  Here's Why NxStage Medical, Inc.'s Stock Is Popping Today at Motley Fool +13.32%
10:55AM  Edited Transcript of NXTM earnings conference call or presentation 3-Nov-16 1:00pm GMT
10:24AM  NxStage Medical Sees Better Times Ahead at Motley Fool
08:44AM  NxStage tops Street 3Q forecasts
08:20AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
08:01AM  NxStage Reports Third Quarter Financial Results; Raises Full-Year Revenue Guidance And Cuts Net Loss Guidance In Half PR Newswire
07:07AM  Q3 2016 NxStage Medical Inc Earnings Release - Before Market Open
Nov-01-16 08:00AM  NxStage Announces Fourth Quarter 2016 Investor Conference Schedule PR Newswire
Oct-25-16 08:00AM  NxStage Announces Publication of Journal Supplement with Major Clinical Reviews Supporting More Frequent Hemodialysis Therapy PR Newswire
Oct-21-16 08:00AM  NxStage Highlights Innovative Nx2me Platform Data at Partners HealthCare Connected Health Symposium & Expo 2016 PR Newswire
Oct-12-16 08:46AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : October 12, 2016
Oct-06-16 08:58AM  NxStage® to Report Third Quarter 2016 Financial Results PR Newswire
Oct-04-16 08:38AM  NxStage Medical Forms Partnership with Satellite Healthcare
Oct-03-16 08:00AM  NxStage and Satellite Healthcare Announce New Three-Year Home Hemodialysis Agreement that Includes Innovative Nx2me Platform PR Newswire
Sep-13-16 11:47AM  NxStage Medical, Inc. Value Analysis (NASDAQ:NXTM) : September 13, 2016
Sep-12-16 08:47AM  NxStage Medical, Inc. breached its 50 day moving average in a Bearish Manner : NXTM-US : September 12, 2016
Aug-29-16 11:53AM  ETFs with exposure to NxStage Medical, Inc. : August 29, 2016
Aug-08-16 08:00AM  NxStage Launches First of Many NxGen Features and Capabilities PR Newswire
Aug-05-16 10:43AM  NxStage Medical, Inc. :NXTM-US: Earnings Analysis: Q2, 2016 By the Numbers : August 5, 2016
Aug-04-16 06:50PM  Edited Transcript of NXTM earnings conference call or presentation 4-Aug-16 1:00pm GMT +8.31%
08:59AM  NxStage reports 2Q loss
08:17AM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements and Exh
08:06AM  NxStage Reports Second Quarter Financial Results And Raises Full-Year Revenue Guidance PR Newswire
07:07AM  Q2 2016 NxStage Medical Inc Earnings Release - Before Market Open
Aug-03-16 10:56AM  Medical Product Stock Earnings on Aug 4: NXTM, AGIO & More
Aug-02-16 08:00AM  NxStage to Present at Canaccord Genuity 36th Annual Growth Conference PR Newswire
Jul-21-16 08:00AM  Macon Dialysis Center Grand Opening PR Newswire
Jul-19-16 04:32PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jul-18-16 09:17AM  Bet on These 5 Profitable Stocks to Boost Your Returns
Jul-13-16 08:30AM  Boston Scientific's Restructuring Plan & Innovation Offer Hope
Jul-12-16 08:17PM  FDA Okays Medtronic's NuVent for Expanded Use in Sinusitis
Jul-08-16 10:27AM  Illumina Stock Hit by Downbeat Guidance, Stiff Competition
08:54AM  Halyard Health Now a Strong Buy, Portfolio Key Catalyst
Jul-01-16 08:30AM  NxStage® to Report Second Quarter 2016 Financial Results PR Newswire
Jun-28-16 09:26AM  Nxstage Medical upgraded by Northland Capital +6.37%
Jun-27-16 05:01PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Change in Directors or Principal Officers
Jun-22-16 07:57AM  Nextcom Ltd. (Israel) :NXTM-IL: Earnings Analysis: Q1, 2016 By the Numbers : June 22, 2016
Jun-13-16 05:26PM  NXSTAGE MEDICAL, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement
Jun-09-16 08:40AM  Nxstage Medical (NXTM) Catches Eye: Stock Jumps 5.6%
NxStage Medical, Inc., a medical technology company, develops, manufactures, and markets products and services for patients suffering from chronic or acute kidney failure. Its primary product includes the System One, a portable hemodialysis system, which is used primarily for home hemodialysis and a range of dialysis therapies to deliver in the home setting. The company operates through three segments: System One, In-Center, and Services. The System One segment sells and rents the NxStage System One and PureFlow SL dialysate preparation equipment, as well as sells disposable products in the home market for the treatment of end-stage renal disease (ESRD) patients in the home or a home-like setting and in the critical care market for the treatment of hospital-based patients with acute kidney failure or fluid overload. The In-Center segment engages in the sale of blood tubing sets and needles for hemodialysis primarily for the treatment of ESRD patients at dialysis centers, and needles for apheresis. The Services segment offers dialysis services to patients at NxStage Kidney Care dialysis centers. NxStage Medical, Inc. markets its products through direct sales and distributors to hospitals and dialysis centers in the United States and internationally. The company was formerly known as QB Medical, Inc. and changed its name to NxStage Medical, Inc. NxStage Medical, Inc. was founded in 1998 and is headquartered in Lawrence, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Turk Joseph E JrPresidentNov 28Option Exercise18.482,66949,32382,449Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 28Sale26.482,66970,67579,780Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 25Option Exercise13.029,500123,68589,280Nov 29 05:07 PM
Turk Joseph E JrPresidentNov 25Sale25.879,500245,81079,780Nov 29 05:07 PM
Burbank Jeffrey HChief Executive OfficerNov 23Sale24.017,500180,075897,616Nov 23 06:07 PM
Swan Winifred LSVP and General CounselNov 22Option Exercise11.033,00033,09014,973Nov 22 06:00 PM
Swan Winifred LSVP and General CounselNov 22Sale25.513,00076,53011,973Nov 22 06:00 PM
Burbank Jeffrey HChief Executive OfficerNov 22Sale25.517,500191,325905,116Nov 22 05:56 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 21Option Exercise14.054,30060,41523,041Nov 21 05:00 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeNov 21Sale26.234,300112,78918,741Nov 21 05:00 PM
Giannini Daniel ADirectorNov 21Sale25.966,449167,41663,193Nov 22 06:28 PM
Turk Joseph E JrPresidentNov 17Sale25.971,00025,97079,780Nov 18 05:00 PM
Turk Joseph E JrPresidentNov 16Sale26.2622,500590,85080,780Nov 16 06:49 PM
Mixer Jean KDirectorNov 14Option Exercise11.0011,579127,36911,579Nov 16 04:07 PM
LEWIS EARL RDirectorNov 02Option Exercise14.2333,468476,393108,786Nov 04 06:42 PM
MOORE CRAIG WDirectorSep 14Sale23.601,50035,40089,239Sep 14 05:14 PM
MOORE CRAIG WDirectorSep 12Sale23.021,50034,53090,739Sep 14 05:14 PM
Giannini Daniel ADirectorAug 04Option Exercise14.9915,272228,92779,245Aug 08 04:14 PM
LEWIS EARL RDirectorMay 25Option Exercise18.5514,000259,70089,125May 27 05:21 PM
Giannini Daniel ADirectorMay 25Option Exercise18.5514,000259,70077,780May 27 05:14 PM
MOORE CRAIG WDirectorMay 25Option Exercise18.5514,000259,700106,046May 27 05:00 PM
REID PERPERDirectorMay 25Option Exercise18.557,000129,850127,483May 27 04:42 PM
Turk Joseph E JrPresidentMay 12Sale17.891,50026,835103,280May 12 04:49 PM
Turk Joseph E JrPresidentMay 10Option Exercise9.961,05710,528105,837May 11 06:14 PM
Turk Joseph E JrPresidentMay 10Sale18.001,05719,026104,780May 11 06:14 PM
Swan Winifred LSVP and General CounselApr 14Option Exercise9.966196,16514,473Apr 15 05:35 PM
Swan Winifred LSVP and General CounselApr 14Sale14.952,50037,37511,973Apr 15 05:35 PM
Turk Joseph E JrPresidentApr 05Option Exercise9.961,0009,960109,280Apr 06 04:56 PM
Turk Joseph E JrPresidentApr 05Sale15.052,50037,625106,780Apr 06 04:56 PM
Turk Joseph E JrPresidentMar 22Sale14.342,00028,680108,280Mar 23 04:21 PM
Swan Winifred LSVP and General CounselMar 14Option Exercise9.966206,17518,234Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.696209,72817,614Mar 15 04:49 PM
Swan Winifred LSVP and General CounselMar 14Sale15.691,88029,49713,854Apr 15 05:35 PM
Turk Joseph E JrPresidentMar 10Option Exercise9.961,0009,960112,780Mar 10 04:28 PM
Turk Joseph E JrPresidentMar 10Sale15.582,50038,950110,280Mar 10 04:28 PM
Brown Robert S.President, NxStage Kidney CareMar 03Option Exercise0.009,746069,523Mar 07 04:14 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeMar 03Option Exercise0.009,746022,693Mar 07 04:07 PM
Turk Joseph E JrPresidentMar 03Option Exercise0.009,7460114,909Mar 07 04:35 PM
Swan Winifred LSVP and General CounselMar 03Option Exercise0.007,919020,358Mar 07 04:35 PM
Burbank Jeffrey HChief Executive OfficerMar 03Option Exercise0.0028,0210921,762Mar 07 04:28 PM
Turk Joseph E JrPresidentFeb 24Option Exercise2.119922,093108,155Feb 25 04:07 PM
Straube Barry MDirectorFeb 24Buy14.201,50021,3001,500Feb 25 04:07 PM
Turk Joseph E JrPresidentFeb 24Sale14.122,99242,247105,163Feb 25 04:07 PM
Swan Winifred LSVP and General CounselFeb 16Option Exercise9.966206,17514,939Feb 18 04:21 PM
Swan Winifred LSVP and General CounselFeb 16Sale14.072,50035,17512,439Feb 18 04:21 PM
LEWIS EARL RDirectorFeb 12Buy14.6321,000307,16088,145Feb 17 07:35 AM
Turk Joseph E JrPresidentFeb 09Option Exercise9.961,0009,960109,663Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 09Sale16.882,50042,200107,163Feb 10 04:56 PM
Turk Joseph E JrPresidentFeb 04Option Exercise2.119912,091109,654Feb 05 04:07 PM
Turk Joseph E JrPresidentFeb 04Sale19.6099119,424108,663Feb 05 04:07 PM
Turk Joseph E JrPresidentJan 20Sale18.752,00037,500108,663Jan 21 04:21 PM
Swan Winifred LSVP and General CounselJan 14Option Exercise9.966206,17514,939Jan 15 04:07 PM
Swan Winifred LSVP and General CounselJan 14Sale19.0462011,80514,319Jan 15 04:07 PM
Swan Winifred LSVP and General CounselJan 14Sale19.041,88035,79515,734Apr 15 05:35 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 11Option Exercise14.053,47248,78216,419Jan 11 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeJan 11Sale20.403,47270,82912,947Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 08Option Exercise11.031,50016,545112,163Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 08Sale21.031,50031,545110,663Jan 11 04:21 PM
Turk Joseph E JrPresidentJan 07Option Exercise9.962,21322,041114,376Jan 08 04:42 PM
Turk Joseph E JrPresidentJan 07Sale20.783,71377,156110,663Jan 08 04:42 PM
Turk Joseph E JrPresidentDec 31Option Exercise7.7211,20086,432112,163Jan 04 04:21 PM
Turk Joseph E JrPresidentDec 22Option Exercise11.033,00033,090105,963Dec 23 04:07 PM
Turk Joseph E JrPresidentDec 22Sale20.925,000104,600100,963Dec 23 04:07 PM
Turk Joseph E JrPresidentDec 16Option Exercise9.968007,968103,763Dec 17 04:21 PM
Turk Joseph E JrPresidentDec 16Sale19.9980015,992102,963Dec 17 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 15Option Exercise14.052,86340,22515,810Dec 17 04:21 PM
TOWSE MATTHEW WSVP and Chief Financial OfficeDec 15Sale19.512,86355,85712,947Dec 17 04:21 PM
Swan Winifred LSVP and General CounselDec 14Option Exercise9.966206,17516,819Dec 15 04:21 PM
Swan Winifred LSVP and General CounselDec 14Sale18.902,50047,25014,319Dec 15 04:21 PM